Benign prostatic hyperplasia (BPH) is the most common benign prostate disease in elderly men, and its incidence increases with age and is associated with lower urinary tract symptoms (LUTS). The international prostate symptoms score (IPSS) is the most common symptom score used to assess LUTS even though other symptom scores exist. This study aims to evaluate the LUTS of patients secondary to BPH presenting to the urology clinic of UPTH using the IPSS and to review other scoring systems. Materials and Methods: This was a prospective hospital based descriptive cross-sectional study carried out in University of Port Harcourt Teaching Hospital (UPTH). All adult male patients with LUTS secondary to BPE were given an IPSS questionnaire to fill. Another IPSS questionnaire was filled by the patient assisted by the researcher. The data were collated using Microsoft Excel 2016 version and they were analyzed using SPSS version 20. Results were presented in tables. Results: Sixty-nine (69%) patients had at least secondary level of education. Sixty-four (64%) could complete their questionnaire without any aid. The mean IPSS was 22.13 ± 6.34 as most patients presented with severe symptoms. The mean Quality of Life score was 4.60 ± 1.38. There was a significant positive correlation between Quality of Life and IPSS. Conclusion: A level of literacy is needed to complete the questionnaire. Most patients in our study presented late with severe symptoms and significant level of bother. Nocturia was the worst symptom.
References
[1]
Li, J., Peng, L., Cao, D., Gou, H., Li, Y. and Wei, Q. (2020) The Association between Metabolic Syndrome and Benign Prostatic Hyperplasia: A Systematic Review and Meta-Analysis. The Aging Male, 23, 1388-1399. https://doi.org/10.1080/13685538.2020.1771552
[2]
Yeo, J.K., Choi, H., Bae, J.H., Kim, J.H., Yang, S.O., Oh, C.Y., Cho, Y.S., Kim, K.W., Kim, H.J. and Yang, S.K. (2016) Korean Clinical Practice Guideline for Benign Prostatic Hyperplasia. Investigative and Clinical Urology, 57, 30-44. https://doi.org/10.4111/icu.2016.57.1.30
[3]
Alrabadi, A., Al Demour, S., Mansi, H., AlHamss, S. and Al Omari, L. (2020) Evaluation of Voiding Position on Uroflowmetry Parameters and Post Void Residual Urine in Patients with Benign Prostatic Hyperplasia and Healthy Men. American Journal of Men’s Health, 14, Article ID: 1557988320938969. https://doi.org/10.1177/1557988320938969
[4]
Chute, C.G.,Panser, L.A., Girman, C.J., Oesterling, J.E., Guess, H.A., Jacobsen, S.J. and Lieber, M.M. (1993) The Prevalence of Prostatism: A Population-Based Survey of Urinary Symptoms. Journal of Urology, 150, 85-89. https://doi.org/10.1016/S0022-5347(17)35405-8
[5]
Yesil, H., Akkoc, Y., Karapolat, H., Güler, A., Sungur, U., Evyapan, D. and Gokcay, F. (2017) Reliability and Validity of the Turkish Version of the Danish Prostatic Symptom Score to Assess Lower Urinary Tract Symptoms in Stroke Patients. NeuroRehabilitation, 41, 429-435. https://doi.org/10.3233/NRE-162136
[6]
Ölçücü, M.T., Aydın, M.E., Avcı, S., Koraş, Ö., Eren, A.E., Yılmaz, K. and Ateş, M. (2020) Comparison of a Visual Prostate Symptom Score and International Prostate Symptom Score: A Prospective Multicenter Study and Literature Review. Urology, 146, 230-235. https://doi.org/10.1016/j.urology.2020.09.001
[7]
Fujimura, T., Kume, H., Nishimatsu, H., Sugihara, T., Nomiya, A., Tsurumaki, Y., Miyazaki, H., Suzuki, M., Fukuhara, H., Enomoto, Y. and Homma, Y. (2012) Assessment of Lower Urinary Tract Symptoms in Men by International Prostate Symptom Score and Core Lower Urinary Tract Symptom Score. BJU International, 109, 1512-1516. https://doi.org/10.1111/j.1464-410X.2011.10445.x
[8]
Miller, L.E., Chughtai, B., McVary, K., Gonzalez, R.R., Rojanasarot, S., DeRouen, K. and Bhattacharyya, S. (2020) Water Vapor Thermal Therapy for Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia: Systematic Review and Meta-Analysis. Medicine, 99, Article ID: e21365. https://doi.org/10.1097/MD.0000000000021365
[9]
Abhulimen, V. and Raphael, J. (2021) Correlation between Uroflowmetry and International Prostate Symptoms Score in the Evaluation of Nigerian Men with Benign Prostatic Enlargement: Correlation between Uroflowmetry and IPSS. Nigerian Medical Journal, 62, 219-225.
[10]
Ogwuche, E.I., Dakum, N.K., Amu, C.O., Dung, E.D., Udeh, E. and Ramyil, V.M. (2013) Problems with Administration of International Prostate Symptom Score in a Developing Community. Annals of African Medicine, 12, 171-173. https://doi.org/10.4103/1596-3519.117628
[11]
Araoye, M.O. (2003) Research Methodology with Statistics for Health and Social Sciences. Nathadex Publishers, Ilorin, Nigeria, 115-129.
[12]
Agrawal, C.S., Chalise, P.R. and Bhandari, B.B. (2008) Correlation of Prostate Volume with International Prostate Symptom Score and Quality of Life in Men with Benign Prostatic Hyperplasia. Nepal Medical College Journal, 10, 104-107.
[13]
Mfonobong, D. (2022) Top 10 Most Educated States in Nigeria.
[14]
Auffenberg, G., Helfan, B. and Mcvary, K. (2009) Established Medical Therapy for Benign Prostatic Hyperplasia. Urologic Clinics of North America, 36, 443-445. https://doi.org/10.1016/j.ucl.2009.07.004
[15]
Oranusi, C.K., Nwofor, A.E. and Mbonu, O. (2017) Correlation between International Prostate Symptom Score and Uroflowmetry in Patients with Benign Prostatic Hyperplasia. Nigerian Journal of Clinical Practice, 20, 454-458.
[16]
Tanimola, M.A. and Owoyemi, J.O. (2009) Healthcare-Seeking Behaviour in Anyigba, North Central, Nigeria. Research Journal of Medical Sciences, 3, 47-51.
[17]
Olasehinde, N. (2018) Healthcare Seeking Behavior in Nigeria. Journal of Population and Social Studies, 26, 207-218. https://doi.org/10.25133/JPSSv26n3.015
[18]
Latunji, O.O. and Akinyemi, O.O. (2018) Factors Influencing Health-Seeking Behaviour among Civil Servants in Ibadan, Nigeria. Annals of Ibadan Postgraduate Medicine, 16, 52-60.
[19]
Heyns, C.F., van der Walt, C.L. and Groeneveld, A.E. (2012) Correlation between a New Visual Prostate Symptom Score (VPSS) and Uroflowmetry Parameters in Men with Lower Urinary Tract Symptoms. South African Medical Journal, 102, 237-240.
[20]
Park, Y.W. and Lee, J.H. (2014) Correlation between the Visual Prostate Symptom Score and International Prostate Symptom Score in Patients with Lower Urinary Tract Symptoms. International Neurourology Journal, 18, 37-41. https://doi.org/10.5213/inj.2014.18.1.37
[21]
Hansen, B.J., Flyger, H., Brasso, K., Schlou, J., Nordling, J., Thorup Anedrson, J., et al. (1995) Validation of the Self-Administered Danish Prostatic Symptom Score (DAN-PSS-1) System for Use in Benign Prostatic Hyperplasia. British Journal of Urology, 76, 451-458. https://doi.org/10.1111/j.1464-410X.1995.tb07744.x
[22]
Hansen, B.J., Mortensen, S., Mensink, H.J., Flyger, H., Riehmann, M., Hendolin, N., et al. (1998) Comparison of the Danish Prostatic Symptom Score with the International Prostatic Symptom Score, the Madsen-Iversen and Boyarsky Symptom Indexes. ALFECH Study Group. British Journal of Urology, 81, 36-41. https://doi.org/10.1046/j.1464-410x.1998.00524.x
[23]
Donovan, J.L., Peters, T.J., Abrams, P., Brookes, S.T., de aa Rosette, J.J. and Schafer, W. (2000) Scoring the Short Form ICSmaleSF Questionnaire. Journal of Urology, 164, 1948-1955. https://doi.org/10.1016/S0022-5347(05)66926-1
[24]
Abrams, P., Cardozo, L., Fall, M., Griffiths, D., Rosier, P., Ulmsten, U., et al. (2002) The Standardisation of Terminology of Lower Urinary Tract Function: Report from the Standardisation Sub-Committee of the International Continence Society. Neurourology and Urodynamics, 21, 167-178. https://doi.org/10.1002/nau.10052
[25]
Yukio, H., Masaki, Y., Tomonori, Y. and Momokazu, G. (2008) Core Lower Urinary Tract Symptom Score (CLSS) Questionnaire: A Reliable Tool in the Overall Assessment of Lower Urinary Tract Symptoms. International Journal of Urology, 15, 816-820. https://doi.org/10.1111/j.1442-2042.2008.02121.x
[26]
Chen, S.C. (2008) Comparison of ICUD, AUA and EAU Treatment Guidelines for Male LUTS/BPH. Incontinence & Pelvic Floor Dysfunction, 2, 11-16.
[27]
Angalakuditi, M., Seifert, R.F., Hayes, R.P., O’Leary, M.P. and Viktrup, L. (2010) Measurement Properties of the Benign Prostatic Hyperplasia Impact Index in Tadalafil Studies. Health and Quality of Life Outcomes, 8, Article No. 131. https://doi.org/10.1186/1477-7525-8-131
